Plasma concentration of levodopa in Parkinsonism before and after inhibition of peripheral decarboxylase.

Suppr

超能文献

作者信息

Reid J L, Calne D B, Vakil S D, Allen J G, Davies C A

出版信息

J Neurol Sci. 1972 Sep;17(1):45-51. doi: 10.1016/0022-510x(72)90021-4.

DOI:10.1016/0022-510x(72)90021-4

PMID:4560435

Abstract

摘要

相似文献

Plasma concentration of levodopa in Parkinsonism before and after inhibition of peripheral decarboxylase.

J Neurol Sci. 1972 Sep;17(1):45-51. doi: 10.1016/0022-510x(72)90021-4.

Modification of levodopa effect by systemic decarboxylase inhibition.

Arch Neurol. 1973 Feb;28(2):91-5. doi: 10.1001/archneur.1973.00490200039004.

Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease.左旋多巴与MK 486（L-α-甲基多巴肼）联合应用——一种帕金森病外周脱羧酶抑制剂。

Med J Aust. 1974 Mar 23;1(12):429-32.

[2-year experiences with a combination treatment of Parkinsonism with L-dopa and a decarboxylase inhibitor (Benserazid, Ro 4-4602)].左旋多巴与脱羧酶抑制剂（苄丝肼，Ro 4-4602）联合治疗帕金森病的2年经验

Wien Med Wochenschr. 1974 Jun 1;124(22):340-4.

[Parkinson's syndrome. 4 years of experience in treatment with L Dopa associated with a decarboxylase inhibitor. Clinical and biochemical study].[帕金森综合征。左旋多巴与脱羧酶抑制剂联合治疗4年的经验。临床与生化研究]

Nouv Presse Med. 1973 Feb 3;2(5):315-6.

"On-off" phenomenon with levodopa therapy in Parkinsonism. Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine.帕金森病左旋多巴治疗中的“开-关”现象。临床与药理学相关性及肌肉注射维生素B6的作用

Neurology. 1974 May;24(5):431-41. doi: 10.1212/wnl.24.5.431.

[Treatment of Parkinson's syndrome with L-dopa and its methylated derivatives: 3-OMD and 4-OMD associated with a decarboxylase inhibitor. Clinical and biochemical study].[左旋多巴及其甲基化衍生物（3 - OMD和4 - OMD）联合脱羧酶抑制剂治疗帕金森综合征：临床与生化研究]

Schweiz Med Wochenschr. 1973 Oct 20;103(42):1466-74.

[Therapy of Parkinsonism using L-dopa in combination with a decarboxylase inhibitor].使用左旋多巴联合脱羧酶抑制剂治疗帕金森病

Fortschr Neurol Psychiatr Grenzgeb. 1972 Oct;40(10):564-8.

[Comparison of the effect of L-Dopa and of an L-Dopa+decarboxylase inhibitor combination in Parkinson's disease].

Arch Psychiatr Nervenkr (1970). 1973 Mar 19;217(1):95-112. doi: 10.1007/BF02552835.

[Potentiation of L-Dopa in parkinsonism by means of an inhibitor of peripheral decarboxylation].

Rev Med Chil. 1973 Jun;101(6):452-5.

引用本文的文献

Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study.帕金森病中的刺蒺藜豆：一项双盲临床与药理学研究。

J Neurol Neurosurg Psychiatry. 2004 Dec;75(12):1672-7. doi: 10.1136/jnnp.2003.028761.

"On-off" phenomena related to high plasma levodopa.与高血浆左旋多巴相关的“开-关”现象。

Br Med J. 1973 Jun 16;2(5867):641-3. doi: 10.1136/bmj.2.5867.641.

Gout induced by L-dopa and decarboxylase inhibitors.左旋多巴和脱羧酶抑制剂诱发的痛风。

Postgrad Med J. 1976 Apr;52(606):232-3. doi: 10.1136/pgmj.52.606.232.

Clinical pharmacokinetics of levodopa in parkinson's disease.帕金森病中左旋多巴的临床药代动力学

Clin Pharmacokinet. 1976;1(5):313-38. doi: 10.2165/00003088-197601050-00001.

Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.左旋多巴与脱羧酶抑制剂：其临床药理学及在帕金森病治疗中的应用综述

Drugs. 1976;11(5):329-77. doi: 10.2165/00003495-197611050-00001.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验